ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2011

Dec 12, 2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	LIVING CELL TECHNOLOGIES LTD
ABN	14 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	BERNARD TUCH
Date of last notice	20 JULY 2011

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT	INDIRECT
Nature of indirect interest	DIRECTOR
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change	12 DECEMBER 2011
No. of securities held prior to change	36,800	FULLY	PAID	ORDINARY
	SHARES HELD IN		THE NAME OF DTU
	PTY LIMITED ATF		THE BERYL SUPER
	FUND
Class	OPTIONS
Number acquired	400,000
Number disposed	NIL
Value/Consideration	NIL
Note: If consideration is non-cash, provide details and estimated
valuation

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	36,800FULLYPAIDORDINARY
	SHARES HELD IN THE NAME OF DTU
	PTY LIMITED ATF THE BERYL SUPER
	FUND
	150,000 OPTIONS EXERCISE PRICE
	$0.10EACHVESTING18/07/2012
	EXPIRING 12/12/2016 HELD IN THE
	NAME OF DTU PTY LIMITED ATF THE
	BERYL SUPER FUND
	250,000 OPTIONS EXERCISE PRICE
	$0.20EACHVESTING18/07/2012
	EXPIRING 12/12/2016 HELD IN THE
	NAME OF DTU PTY LIMITED ATF THE
	BERYL SUPER FUND
Nature of change	ISSUE OF OPTIONS APPROVED BY
Example: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back	SHAREHOLDER AT THE 2011 ANNUALGENERAL MEETING

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest after change

Part 3 –[+] Closed period

	Part 3 –+Closed period
	Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	NO
	If so, was prior written clearance provided to allow the trade	N/A
	to proceed during this period?
	If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3